Document Detail


Early oral cysteamine therapy for nephropathic cystinosis.
MedLine Citation:
PMID:  14610675     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONCLUSIONS: Early diagnosis and treatment of nephropathic cystinosis can change the course of this disease.
Authors:
William A Gahl
Related Documents :
8151465 - Renal acidification in children with idiopathic hypercalciuria.
5101785 - Renal potassium wasting in renal tubular acidosis (rta): its occurrence in types 1 and ...
2283995 - Interorgan glutamine flow regulation in metabolic acidosis.
2576285 - Evaluation of the nephrotoxicity of aromatic nitro-amino compounds by urinary enzyme ac...
8266425 - Combined team effort in liver procurement and transplantation: 5-year experience of one...
17511565 - Transplantation of 3d scaffolds seeded with human embryonic stem cells: biological feat...
Publication Detail:
Type:  Journal Article; Review     Date:  2003-11-11
Journal Detail:
Title:  European journal of pediatrics     Volume:  162 Suppl 1     ISSN:  0340-6199     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  2003 Dec 
Date Detail:
Created Date:  2003-12-16     Completed Date:  2004-04-15     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  S38-41     Citation Subset:  IM    
Affiliation:
Section on Human Biochemical Genetics, National Institute of Child Health and Human Development, National Institutes of Health, MSC 1851 Building 10, Room 10C-103, 10 Center Drive, Bethesda, Maryland 20892-1851, USA. bgahl@helix.nih.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Cysteamine / administration & dosage,  therapeutic use*
Cystinosis* / diagnosis,  drug therapy,  physiopathology
Humans
Infant
Infant, Newborn
Neonatal Screening / methods*
Radiation-Protective Agents / administration & dosage,  therapeutic use*
Chemical
Reg. No./Substance:
0/Radiation-Protective Agents; 60-23-1/Cysteamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lysosomal storage disorders: emerging therapeutic options require early diagnosis.
Next Document:  Electron tomographic analysis of post-meiotic cytokinesis during pollen development in Arabidopsis t...